<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36107840</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1549-1676</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>PLoS medicine</Title><ISOAbbreviation>PLoS Med</ISOAbbreviation></Journal><ArticleTitle>Hospital-treated infections in early- and mid-life and risk of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis: A nationwide nested case-control study in Sweden.</ArticleTitle><Pagination><StartPage>e1004092</StartPage><MedlinePgn>e1004092</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1004092</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pmed.1004092</ELocationID><Abstract><AbstractText Label="BACKGROUND">Experimental observations have suggested a role of infection in the etiology of neurodegenerative disease. In human studies, however, it is difficult to disentangle whether infection is a risk factor or rather a comorbidity or secondary event of neurodegenerative disease. To this end, we examined the risk of 3 most common neurodegenerative diseases in relation to previous inpatient or outpatient episodes of hospital-treated infections.</AbstractText><AbstractText Label="METHODS AND FINDINGS">We performed a nested case-control study based on several national registers in Sweden. Cases were individuals newly diagnosed with Alzheimer's disease (AD), Parkinson's disease (PD), or amyotrophic lateral sclerosis (ALS) during 1970 to 2016 in Sweden, identified from the National Patient Register. For each case, 5 controls individually matched to the case on sex and year of birth were randomly selected from the general population. Conditional logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) with adjustment for potential confounders, including sex, year of birth, area of residence, educational attainment, family history of neurodegenerative disease, and Charlson comorbidity index. Infections experienced within 5 years before diagnosis of neurodegenerative disease were excluded to reduce the influence of surveillance bias and reverse causation. The analysis included 291,941 AD cases (median age at diagnosis: 76.2 years; male: 46.6%), 103,919 PD cases (74.3; 55.1%), and 10,161 ALS cases (69.3; 56.8%). A hospital-treated infection 5 or more years earlier was associated with an increased risk of AD (OR = 1.16, 95% CI: 1.15 to 1.18, P &lt; 0.001) and PD (OR = 1.04, 95% CI: 1.02 to 1.06, P &lt; 0.001). Similar results were observed for bacterial, viral, and other infections and among different sites of infection including gastrointestinal and genitourinary infections. Multiple infections before age 40 conveyed the greatest risk of AD (OR = 2.62, 95% CI: 2.52 to 2.72, P &lt; 0.001) and PD (OR = 1.41, 95% CI: 1.29 to 1.53, P &lt; 0.001). The associations were primarily due to AD and PD diagnosed before 60 years (OR = 1.93, 95% CI: 1.89 to 1.98 for AD, P &lt; 0.001; OR = 1.29, 95% CI: 1.22 to 1.36 for PD, P &lt; 0.001), whereas no association was found for those diagnosed at 60 years or older (OR = 1.00, 95% CI: 0.98 to 1.01 for AD, P = 0.508; OR = 1.01, 95% CI: 0.99 to 1.03 for PD, P = 0.382). No association was observed for ALS (OR = 0.97, 95% CI: 0.92 to 1.03, P = 0.384), regardless of age at diagnosis. Excluding infections experienced within 10 years before diagnosis of neurodegenerative disease confirmed these findings. Study limitations include the potential misclassification of hospital-treated infections and neurodegenerative diseases due to incomplete coverage of the National Patient Register, as well as the residual confounding from unmeasured risk or protective factors for neurodegenerative diseases.</AbstractText><AbstractText Label="CONCLUSIONS">Hospital-treated infections, especially in early- and mid-life, were associated with an increased risk of AD and PD, primarily among AD and PD cases diagnosed before 60 years. These findings suggest that infectious events may be a trigger or amplifier of a preexisting disease process, leading to clinical onset of neurodegenerative disease at a relatively early age. However, due to the observational nature of the study, these results do not formally prove a causal link.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Jiangwei</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2252-684X</Identifier><AffiliationInfo><Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ludvigsson</LastName><ForeName>Jonas F</ForeName><Initials>JF</Initials><Identifier Source="ORCID">0000-0003-1024-5602</Identifier><AffiliationInfo><Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, &#xd6;rebro University Hospital, &#xd6;rebro, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ingre</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-5327-7204</Identifier><AffiliationInfo><Affiliation>Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piehl</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wirdefeldt</LastName><ForeName>Karin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zagai</LastName><ForeName>Ulrika</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0003-0807-5835</Identifier><AffiliationInfo><Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Weimin</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Fang</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-3310-6456</Identifier><AffiliationInfo><Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 TS000324</GrantID><Acronym>TS</Acronym><Agency>ATSDR CDC HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Med</MedlineTA><NlmUniqueID>101231360</NlmUniqueID><ISSNLinking>1549-1277</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003428" MajorTopicYN="Y">Cross Infection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013548" MajorTopicYN="N" Type="Geographic">Sweden</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>I have read the journal&#x2019;s policy and the authors of this manuscript have the following competing interests: JL coordinates a study (independent of the present study) on behalf of the Swedish IBD quality register (SWIBREG). That study has received funding from Janssen Corporation. Other authors declared no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>15</Day><Hour>13</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36107840</ArticleId><ArticleId IdType="pmc">PMC9477309</ArticleId><ArticleId IdType="doi">10.1371/journal.pmed.1004092</ArticleId><ArticleId IdType="pii">PMEDICINE-D-22-01054</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fang P, Kazmi SA, Jameson KG, Hsiao EY. The Microbiome as a Modifier of Neurodegenerative Disease Risk. Cell Host Microbe. 2020;28(2):201&#x2013;222. doi: 10.1016/j.chom.2020.06.008 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.06.008</ArticleId><ArticleId IdType="pmc">PMC7430034</ArticleId><ArticleId IdType="pubmed">32791113</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols E, Szoeke CEI, Vollset SE, Abbasi N, Abd-Allah F, Abdela J, et al.. Global, regional, and national burden of Alzheimer&#x2019;s disease and other dementias, 1990&#x2013;2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(1):88&#x2013;106. doi: 10.1016/S1474-4422(18)30403-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30403-4</ArticleId><ArticleId IdType="pmc">PMC6291454</ArticleId><ArticleId IdType="pubmed">30497964</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorsey ER, Elbaz A, Nichols E, Abd-Allah F, Abdelalim A, Adsuar JC, et al.. Global, regional, and national burden of Parkinson&#x2019;s disease, 1990&#x2013;2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):939&#x2013;953. doi: 10.1016/S1474-4422(18)30295-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30295-3</ArticleId><ArticleId IdType="pmc">PMC6191528</ArticleId><ArticleId IdType="pubmed">30287051</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G, Piccininni M, Marin B, Nichols E, Abd-Allah F, Abdelalim A, et al.. Global, regional, and national burden of motor neuron diseases 1990&#x2013;2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(12):1083&#x2013;1097. doi: 10.1016/S1474-4422(18)30404-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30404-6</ArticleId><ArticleId IdType="pmc">PMC6234315</ArticleId><ArticleId IdType="pubmed">30409709</ArticleId></ArticleIdList></Reference><Reference><Citation>Cryan JF O &#x2019;Riordan KJ, Sandhu K, Peterson V, Dinan TG. The gut microbiome in neurological disorders. Lancet Neurol. 2020;19(2):179&#x2013;194. doi: 10.1016/S1474-4422(19)30356-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(19)30356-4</ArticleId><ArticleId IdType="pubmed">31753762</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R, Chi&#xf2; A, Traynor BJ. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol. 2018;17(1):94&#x2013;102. doi: 10.1016/S1474-4422(17)30401-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Smeyne RJ, Noyce AJ, Byrne M, Savica R, Marras C. Infection and Risk of Parkinson&#x2019;s Disease. J Parkinsons Dis. 2021;11(1):31&#x2013;43. doi: 10.3233/JPD-202279 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-202279</ArticleId><ArticleId IdType="pmc">PMC7990414</ArticleId><ArticleId IdType="pubmed">33361610</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Huang T, Debelius JW, Fang F. Gut microbiome and amyotrophic lateral sclerosis: A systematic review of current evidence. J Intern Med. 2021;290(4):758&#x2013;788. doi: 10.1111/joim.13336 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13336</ArticleId><ArticleId IdType="pubmed">34080741</ArticleId></ArticleIdList></Reference><Reference><Citation>Lotz SK, Blackhurst BM, Reagin KL, Funk KE. Microbial Infections Are a Risk Factor for Neurodegenerative Diseases. Front Cell Neurosci. 2021;15:691136. doi: 10.3389/fncel.2021.691136 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.691136</ArticleId><ArticleId IdType="pmc">PMC8292681</ArticleId><ArticleId IdType="pubmed">34305533</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutsch A, Kantsjo JB, Ronchi F. The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology. Front Immunol. 2020;11. doi: 10.3389/fimmu.2020.604179 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.604179</ArticleId><ArticleId IdType="pmc">PMC7758428</ArticleId><ArticleId IdType="pubmed">33362788</ArticleId></ArticleIdList></Reference><Reference><Citation>Sait A, Angeli C, Doig AJ, Day PJR. Viral Involvement in Alzheimer&#x2019;s Disease. ACS Chem Nerosci. 2021;12(7):1049&#x2013;1060. doi: 10.1021/acschemneuro.0c00719 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00719</ArticleId><ArticleId IdType="pmc">PMC8033564</ArticleId><ArticleId IdType="pubmed">33687205</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocoros NM, Svensson E, Szepligeti SK, Vestergaard SV, Szentkuti P, Thomsen RW, et al.. Long-term Risk of Parkinson Disease Following Influenza and Other Infections. JAMA Neurol. 2021;78(12):1461&#x2013;1470. doi: 10.1001/jamaneurol.2021.3895 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.3895</ArticleId><ArticleId IdType="pmc">PMC8546623</ArticleId><ArticleId IdType="pubmed">34694344</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Liu X, Tan C, Zhou W, Jiang J, Peng W, et al.. Bacterial, viral, and fungal infection-related risk of Parkinson&#x2019;s disease: Meta-analysis of cohort and case-control studies. Brain Behav. 2020;10(3):e01549. doi: 10.1002/brb3.1549 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.1549</ArticleId><ArticleId IdType="pmc">PMC7066372</ArticleId><ArticleId IdType="pubmed">32017453</ArticleId></ArticleIdList></Reference><Reference><Citation>Dardiotis E, Tsouris Z, Mentis AA, Siokas V, Michalopoulou A, Sokratous M, et al.. H. pylori and Parkinson&#x2019;s disease: Meta-analyses including clinical severity. Clin Neurol Neurosurg. 2018;175:16&#x2013;24. doi: 10.1016/j.clineuro.2018.09.039 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2018.09.039</ArticleId><ArticleId IdType="pubmed">30308319</ArticleId></ArticleIdList></Reference><Reference><Citation>Itzhaki RF, Golde TE, Heneka MT, Readhead B. Do infections have a role in the pathogenesis of Alzheimer disease? Nat Rev Neurol. 2020;16(4):193&#x2013;197. doi: 10.1038/s41582-020-0323-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0323-9</ArticleId><ArticleId IdType="pubmed">32152461</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren-Gash C, Forbes HJ, Williamson E, Breuer J, Hayward AC, Mavrodaris A, et al.. Human herpesvirus infections and dementia or mild cognitive impairment: a systematic review and meta-analysis. Sci Rep. 2019;9(1):4743. doi: 10.1038/s41598-019-41218-w .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-41218-w</ArticleId><ArticleId IdType="pmc">PMC6426940</ArticleId><ArticleId IdType="pubmed">30894595</ArticleId></ArticleIdList></Reference><Reference><Citation>Sipil&#xe4; PN, Heikkil&#xe4; N, Lindbohm JV, Hakulinen C, Vahtera J, Elovainio M, et al.. Hospital-treated infectious diseases and the risk of dementia: a large, multicohort, observational study with a replication cohort. Lancet Infect Dis. 2021;21(11):1557&#x2013;1567. doi: 10.1016/S1473-3099(21)00144-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00144-4</ArticleId><ArticleId IdType="pmc">PMC8592915</ArticleId><ArticleId IdType="pubmed">34166620</ArticleId></ArticleIdList></Reference><Reference><Citation>Muzambi R, Bhaskaran K, Smeeth L, Brayne C, Chaturvedi N, Warren-Gash C. Assessment of common infections and incident dementia using UK primary and secondary care data: a historical cohort study. Lancet Healthy Longev. 2021;2(7):e426&#x2013;e435. doi: 10.1016/S2666-7568(21)00118-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-7568(21)00118-5</ArticleId><ArticleId IdType="pmc">PMC8245326</ArticleId><ArticleId IdType="pubmed">34240064</ArticleId></ArticleIdList></Reference><Reference><Citation>Mawanda F, Wallace RB, McCoy K, Abrams TE. Systemic and localized extra-central nervous system bacterial infections and the risk of dementia among US veterans: A retrospective cohort study. Alzheimers Dement (Amst). 2016;4:109&#x2013;117. doi: 10.1016/j.dadm.2016.08.004 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dadm.2016.08.004</ArticleId><ArticleId IdType="pmc">PMC5061465</ArticleId><ArticleId IdType="pubmed">27752534</ArticleId></ArticleIdList></Reference><Reference><Citation>Douros A, Santella C, Dell&#x2019;Aniello S, Azoulay L, Renoux C, Suissa S, et al.. Infectious Disease Burden and the Risk of Alzheimer&#x2019;s Disease: A Population-Based Study. J Alzheimers Dis. 2021;81(1):329&#x2013;338. doi: 10.3233/JAD-201534 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-201534</ArticleId><ArticleId IdType="pubmed">33780369</ArticleId></ArticleIdList></Reference><Reference><Citation>Celeste DB, Miller MS. Reviewing the evidence for viruses as environmental risk factors for ALS: A new perspective. Cytokine. 2018;108:173&#x2013;178. doi: 10.1016/j.cyto.2018.04.010 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2018.04.010</ArticleId><ArticleId IdType="pubmed">29684753</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al.. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450. doi: 10.1186/1471-2458-11-450 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-11-450</ArticleId><ArticleId IdType="pmc">PMC3142234</ArticleId><ArticleId IdType="pubmed">21658213</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzuto D, Feldman AL, Karlsson IK, Dahl Aslan AK, Gatz M, Pedersen NL. Detection of Dementia Cases in Two Swedish Health Registers: A Validation Study. J Alzheimers Dis. 2018;61(4):1301&#x2013;1310. doi: 10.3233/JAD-170572 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-170572</ArticleId><ArticleId IdType="pmc">PMC6218116</ArticleId><ArticleId IdType="pubmed">29376854</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman AL, Johansson AL, Gatz M, Flensburg M, Petzinger GM, Widner H, et al.. Accuracy and sensitivity of Parkinsonian disorder diagnoses in two Swedish national health registers. Neuroepidemiology. 2012;38(3):186&#x2013;193. doi: 10.1159/000336356 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000336356</ArticleId><ArticleId IdType="pmc">PMC3375128</ArticleId><ArticleId IdType="pubmed">22472568</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariosa D, Hammar N, Malmstrom H, Ingre C, Jungner I, Ye W, et al.. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort. Ann Neurol. 2017;81(5):718&#x2013;728. doi: 10.1002/ana.24936 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24936</ArticleId><ArticleId IdType="pubmed">28437840</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson DB. An incidence density sampling program for nested case-control analyses. Occup Environ Med. 2004;61(12):e59. doi: 10.1136/oem.2004.014472 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/oem.2004.014472</ArticleId><ArticleId IdType="pmc">PMC1740694</ArticleId><ArticleId IdType="pubmed">15550597</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Smith KA, Hiyoshi A, Piehl F, Olsson T, Montgomery S. Hospital-diagnosed infections before age 20 and risk of a subsequent multiple sclerosis diagnosis. Brain. 2021;144(8):2390&#x2013;2400. doi: 10.1093/brain/awab100 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab100</ArticleId><ArticleId IdType="pubmed">33693538</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson JF, Svedberg P, Olen O, Bruze G, Neovius M. The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research. Eur J Epidemiol. 2019;34(4):423&#x2013;437. doi: 10.1007/s10654-019-00511-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-019-00511-8</ArticleId><ArticleId IdType="pmc">PMC6451717</ArticleId><ArticleId IdType="pubmed">30929112</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekbom A. The Swedish multi-generation register. Methods in biobanking: Springer. 2011:215&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">20949391</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson JF, Appelros P, Askling J, Byberg L, Carrero JJ, Ekstrom AM, et al.. Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden. Clin Epidemiol. 2021;13:21&#x2013;41. doi: 10.2147/CLEP.S282475 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S282475</ArticleId><ArticleId IdType="pmc">PMC7812935</ArticleId><ArticleId IdType="pubmed">33469380</ArticleId></ArticleIdList></Reference><Reference><Citation>Lash TL, VanderWeele TJ, Haneuse S, Rothman KJ. Modern epidemiology. 4th ed: Philadelphia: Wolters Kluwer; 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8416883</ArticleId><ArticleId IdType="pubmed">34216355</ArticleId></ArticleIdList></Reference><Reference><Citation>Labrecque JA, Hunink MMG, Ikram MA, Ikram MK. Do Case-Control Studies Always Estimate Odds Ratios? Am J Epidemiol. 2021;190(2):318&#x2013;321. doi: 10.1093/aje/kwaa167 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwaa167</ArticleId><ArticleId IdType="pmc">PMC7850067</ArticleId><ArticleId IdType="pubmed">32889542</ArticleId></ArticleIdList></Reference><Reference><Citation>Longinetti E, Regodon Wallin A, Samuelsson K, Press R, Zachau A, Ronnevi LO, et al.. The Swedish motor neuron disease quality registry. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19(7&#x2013;8):528&#x2013;537. doi: 10.1080/21678421.2018.1497065 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1497065</ArticleId><ArticleId IdType="pubmed">30296856</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendriks S, Peetoom K, Bakker C, van der Flier WM, Papma JM, Koopmans R, et al.. Global Prevalence of Young-Onset Dementia: A Systematic Review and Meta-analysis. JAMA Neurol. 2021;78(9):1080&#x2013;1090. doi: 10.1001/jamaneurol.2021.2161 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.2161</ArticleId><ArticleId IdType="pmc">PMC8290331</ArticleId><ArticleId IdType="pubmed">34279544</ArticleId></ArticleIdList></Reference><Reference><Citation>Balestrino R, Schapira AHV. Parkinson disease. Eur J Neurol. 2020;27(1):27&#x2013;42. doi: 10.1111/ene.14108 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14108</ArticleId><ArticleId IdType="pubmed">31631455</ArticleId></ArticleIdList></Reference><Reference><Citation>Sims R, Hill M, Williams J. The multiplex model of the genetics of Alzheimer&#x2019;s disease. Nat Neurosci. 2020;23(3):311&#x2013;322. doi: 10.1038/s41593-020-0599-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-0599-5</ArticleId><ArticleId IdType="pubmed">32112059</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Grahn A, Nilsson S, Nordlund A, Linden T, Studahl M. Cognitive impairment 3 years after neurological Varicella-zoster virus infection: a long-term case control study. J Neurol. 2013;260(11):2761&#x2013;2769. doi: 10.1007/s00415-013-7057-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-013-7057-1</ArticleId><ArticleId IdType="pubmed">23900759</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A, Trender W, Chamberlain SR, Jolly AE, Grant JE, Patrick F, et al.. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. 2021;39:101044. doi: 10.1016/j.eclinm.2021.101044 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101044</ArticleId><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopatko Lindman K, Hemmingsson ES, Weidung B, Brannstrom J, Josefsson M, Olsson J, et al.. Herpesvirus infections, antiviral treatment, and the risk of dementia-a registry-based cohort study in Sweden. Alzheimers Dement (N Y). 2021;7(1):e12119. doi: 10.1002/trc2.12119 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/trc2.12119</ArticleId><ArticleId IdType="pmc">PMC7882534</ArticleId><ArticleId IdType="pubmed">33614892</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin WY, Lin MS, Weng YH, Yeh TH, Lin YS, Fong PY, et al.. Association of Antiviral Therapy With Risk of Parkinson Disease in Patients With Chronic Hepatitis C Virus Infection. JAMA Neurol. 2019;76(9):1019&#x2013;1027. doi: 10.1001/jamaneurol.2019.1368 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.1368</ArticleId><ArticleId IdType="pmc">PMC6551582</ArticleId><ArticleId IdType="pubmed">31168563</ArticleId></ArticleIdList></Reference><Reference><Citation>Fearon C, Fasano A. Parkinson&#x2019;s Disease and the COVID-19 Pandemic. J Parkinsons Dis. 2021;11(2):431&#x2013;444. doi: 10.3233/JPD-202320 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-202320</ArticleId><ArticleId IdType="pmc">PMC8150477</ArticleId><ArticleId IdType="pubmed">33492244</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen X, Yang H, Wu Y, Zhang D, Jiang H. Meta-analysis: Association of Helicobacter pylori infection with Parkinson&#x2019;s diseases. Helicobacter. 2017;22(5). doi: 10.1111/hel.12398 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hel.12398</ArticleId><ArticleId IdType="pubmed">28598012</ArticleId></ArticleIdList></Reference><Reference><Citation>Lolekha P, Sriphanom T, Vilaichone RK. Helicobacter pylori eradication improves motor fluctuations in advanced Parkinson&#x2019;s disease patients: A prospective cohort study (HP-PD trial). PLoS ONE. 2021;16(5):e0251042. doi: 10.1371/journal.pone.0251042 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0251042</ArticleId><ArticleId IdType="pmc">PMC8096108</ArticleId><ArticleId IdType="pubmed">33945559</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Li X. Association of Helicobacter pylori treatment with Parkinsonism and related disorders: A systematic review and meta-analysis. Life Sci. 2021;281:119767. doi: 10.1016/j.lfs.2021.119767 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.119767</ArticleId><ArticleId IdType="pubmed">34216625</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Lee MH, Henderson L, Tyagi R, Bachani M, Steiner J, et al.. Human endogenous retrovirus-K contributes to motor neuron disease. Sci Transl Med. 2015;7(307):307ra153. doi: 10.1126/scitranslmed.aac8201 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aac8201</ArticleId><ArticleId IdType="pmc">PMC6344353</ArticleId><ArticleId IdType="pubmed">26424568</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Zhan Y, Mariosa D, Larsson H, Almqvist C, Ingre C, et al.. Antibiotics use and risk of amyotrophic lateral sclerosis in Sweden. Eur J Neurol. 2019;26(11):1355&#x2013;1361. doi: 10.1111/ene.13986 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13986</ArticleId><ArticleId IdType="pubmed">31087715</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL. Can Infections Cause Alzheimer Disease? JAMA. 2020;324(3):239&#x2013;240. doi: 10.1001/jama.2020.4085 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.4085</ArticleId><ArticleId IdType="pubmed">32511670</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibar H, El Bayad K, Bouhouche A, Ait Ben Haddou EH, Benomar A, Yahyaoui M, et al.. Non-Motor Symptoms of Parkinson&#x2019;s Disease and Their Impact on Quality of Life in a Cohort of Moroccan Patients. Front Neurol. 2018;9:170. doi: 10.3389/fneur.2018.00170 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00170</ArticleId><ArticleId IdType="pmc">PMC5893866</ArticleId><ArticleId IdType="pubmed">29670566</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B, Fang F, Pedersen NL, Tillander A, Ludvigsson JF, Ekbom A, et al.. Vagotomy and Parkinson disease: A Swedish register-based matched-cohort study. Neurology. 2017;88(21):1996&#x2013;2002. doi: 10.1212/WNL.0000000000003961 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003961</ArticleId><ArticleId IdType="pmc">PMC5440238</ArticleId><ArticleId IdType="pubmed">28446653</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B, Fang F, Ye W, Wirdefeldt K. Appendectomy, Tonsillectomy and Parkinson&#x2019;s Disease Risk: A Swedish Register-Based Study. Front Neurol. 2020;11:510. doi: 10.3389/fneur.2020.00510 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00510</ArticleId><ArticleId IdType="pmc">PMC7292857</ArticleId><ArticleId IdType="pubmed">32595591</ArticleId></ArticleIdList></Reference><Reference><Citation>Misra MK, Damotte V, Hollenbach JA. The immunogenetics of neurological disease. Immunology. 2018;153(4):399&#x2013;414. doi: 10.1111/imm.12869 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12869</ArticleId><ArticleId IdType="pmc">PMC5838423</ArticleId><ArticleId IdType="pubmed">29159928</ArticleId></ArticleIdList></Reference><Reference><Citation>McMurtray A, Clark DG, Christine D, Mendez MF. Early-onset dementia: frequency and causes compared to late-onset dementia. Dement Geriatr Cogn Disord. 2006;21(2):59&#x2013;64. doi: 10.1159/000089546 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000089546</ArticleId><ArticleId IdType="pubmed">16276111</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch SG, Croteau DL, et al.. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019;15(10):565&#x2013;581. doi: 10.1038/s41582-019-0244-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0244-7</ArticleId><ArticleId IdType="pubmed">31501588</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>